Which hedge funds own ORMP? ORAMED PHARMACEUTICALS INC, Q2 2026 13F holders

13 tracked hedge funds disclosed a position in ORMP (ORAMED PHARMACEUTICALS INC) in their Q2 2026 13F filings, worth $31.1m in total. The largest holder by portfolio weight is Gem Investment Advisors, LLC at 5.9% of its book. 2 opened a new position this quarter: Y-Intercept (Hong Kong) Ltd, Engineers Gate Manager LP. 3 exited: Catalyst Funds Management Pty Ltd, Point72 Asset Management, L.P., Qube Research & Technologies Ltd.

13

Holders

Tracked managers whose filing for the quarter reports a long equity position in the security.

2

New this quarter

Holders whose previous filing (at most two quarters earlier) did not report the security.

3

Exited this quarter

Tracked managers whose previous filing reported the security and whose filing for the quarter does not.

$123k

Inflow, new holders

Combined value of the positions the new holders reported for the quarter.

$248k

Outflow, exits

Combined value the exiting managers reported for the security in their previous filing.

$31.1m

Combined value

Sum of the holders' reported positions in the security.

1.0%

Share of managers holding

Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.